Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene
- PMID: 1657976
Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene
Abstract
Expression of ras oncogenes in NIH 3T3 fibroblasts results in the acquisition by these cells of an invasive potential concomitant with the appearance of cell surface asparagine-linked complex-type glycan structures of a higher average molecular weight (Bolscher, J.G. M., van der Bijl, M. M. W., Neefjes, J. J., Hall, A., Smets, L.A., and Ploegh, H.L. (1988) EMBO J. 7, 3361-3368). We have investigated the enzymatic basis for the altered glycosylation by assessing the activities of all major Golgi glycosyltransferases involved in the synthesis of these structures. Use was made of a stable transfectant cell line (T15) containing the N-ras-protooncogene under the control of a glucocorticoid-inducible mouse mammary tumor virus promoter. Upon induction of the ras gene with dexamethasone: 1) the levels of N-acetylglucosaminyltransferase I and II were essentially unaltered, indicating an unaffected potential to synthesize complex-type glycans; 2) the activities of the branching N-acetylglucosaminyltransferase III and V were elevated 2- to 2.5-fold suggesting the formation of increased amounts of bisected glycans and of structures carrying a Gal beta 1----GlcNAc beta 1----6Man-branch; 3) the levels of the elongating beta 4-galactosyltransferase and beta 3-N-acetylglucosaminyl-transferase were increased 5- to 7-fold indicating a strongly enhanced capacity to synthesize polylactosaminoglycan chains; 4) the level of the major chain-terminating enzyme, alpha 3-galactosyltransferase, was slightly decreased (0.7-fold), whereas those of the alpha 3- and alpha 6-sialyltransferases were slightly elevated (1.3- and 2-fold, respectively), suggesting a shift from termination by alpha-galactosyl residues to termination by sialic acid moieties. Studies on the acceptor specificities of the different glycosyltransferases indicate that these changes occur in a coordinated manner in which the effects of altered glycosyltransferase expression levels amplify each other. Analysis of the size of cell surface complex-type glycopeptides before and after digestion with neuraminidase and endo-beta-galactosidase suggested an increased sialic acid density, an increase in the number and/or length of polylactosaminoglycan chains, and an increased branching of the glycans upon N-ras induction. The enzymatic results explain these structural changes and allow us to define the alterations in glycosylation pathways associated with ras expression.
Similar articles
-
Oncodevelopmental expression of--GlcNAc beta 1-6Man alpha 1-6Man beta 1--branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas.Cancer Res. 1989 Feb 15;49(4):945-50. Cancer Res. 1989. PMID: 2521456
-
Branching beta 1-6N-acetylglucosaminetransferases and polylactosamine expression in mouse F9 teratocarcinoma cells and differentiated counterparts.J Biol Chem. 1993 Jan 15;268(2):1242-51. J Biol Chem. 1993. PMID: 8419327
-
Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis.J Biol Chem. 1991 Jan 25;266(3):1772-82. J Biol Chem. 1991. PMID: 1824844
-
A glycomic approach to the identification and characterization of glycoprotein function in cells transfected with glycosyltransferase genes.Proteomics. 2001 Feb;1(2):239-47. doi: 10.1002/1615-9861(200102)1:2<239::AID-PROT239>3.0.CO;2-K. Proteomics. 2001. PMID: 11680870 Review.
-
Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation.J Biol Chem. 1989 Oct 25;264(30):17615-8. J Biol Chem. 1989. PMID: 2681181 Review. No abstract available.
Cited by
-
Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.Glycoconj J. 2008 Apr;25(3):279-90. doi: 10.1007/s10719-007-9086-4. Epub 2007 Dec 25. Glycoconj J. 2008. PMID: 18158621
-
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.J Exp Med. 1996 Mar 1;183(3):1173-83. doi: 10.1084/jem.183.3.1173. J Exp Med. 1996. PMID: 8642259 Free PMC article.
-
Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analogues.Glycoconj J. 1995 Jun;12(3):371-9. doi: 10.1007/BF00731340. Glycoconj J. 1995. PMID: 7496152
-
Regulation of N-acetylglucosaminyltransferase V by protein kinases.Glycoconj J. 1995 Dec;12(6):767-72. doi: 10.1007/BF00731237. Glycoconj J. 1995. PMID: 8748153
-
Regulation of ST6GAL1 sialyltransferase expression in cancer cells.Glycobiology. 2021 Jun 3;31(5):530-539. doi: 10.1093/glycob/cwaa110. Glycobiology. 2021. PMID: 33320246 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous